Please Wait
Applying Filters...
menu
    • menu
    Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    (E,3R,5S)-7-(2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 9,237Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 Boryung Pharmaceutical Co., Ltd
    South Korea
    		 Boryeong Co., Ltd. 1689-5-ND pitavastatin calcium hydrate 2019-04-10 Boryeong Co., Ltd. South Korea 107, 109 Neungan-ro, Danwon-gu, Ansan-si, Gyeonggi-do
    29/11/2025 CR Double-Crane Pharmaceuticals Co., Ltd
    China
    		 Core Pharm Bio Co., Ltd. Su152-4-ND pitavastatin calcium 2025-09-26 China Resources Double-Crane Pharmaceutical Co.Ltd China No.3, Huatuo Road, West Zone, Lingang Economic and Technological Development Zone, Cangzhou, Hebei Province